Urology · Germantown, MD
NPI
1841413275
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
19851 Observation Dr Ste 455
Germantown, MD, 20876
Phone (301) 933-9660
Groups this clinician bills Medicare through
Medicare paid, 2024
$277K
17,493 services
Medicare patients, 2024
936
Average age 77
Drug cost, 2024
$292K
1,761 prescriptions
Company payments, 2025
$1,142
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Osborn was code J9030 (bcg live intravesical instillation, 1 mg), 1,700 times for 13 patients. In total David J Osborn billed 17,493 services in 97 codes, and Medicare paid $277K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,700 | 13 | $2.24 | $3,802 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,111 | 719 | $13.00 | $14K |
| 81003 Clinical Chemistry | Office | 855 | 596 | $2.18 | $1,868 |
| 99213 Office E&M - Established | Office | 533 | 417 | $71.16 | $38K |
| 99214 Office E&M - Established | Office | 491 | 393 | $106.22 | $52K |
| 51798 Ultrasound - Nonspecific | Office | 402 | 326 | $9.76 | $3,924 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 384 | 64 | $52.95 | $20K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 360 | 61 | $51.83 | $19K |
| 36415 Venipuncture Blood Collection | Office | 229 | 183 | $8.65 | $1,981 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 163 | 49 | $41.16 | $6,709 |
| 52000 Cystourethroscopy | Facility | 116 | 105 | $65.81 | $7,634 |
| 76872 Ultrasound - Nonspecific | Facility | 93 | 93 | $25.61 | $2,381 |
| 55700 Other Organ Systems | Facility | 93 | 93 | $101.90 | $9,477 |
| 99204 Office E&M - New | Office | 70 | 70 | $119.75 | $8,383 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 68 | 67 | $87.36 | $5,940 |
By year: 2022 $202K for 9,582 services; 2023 $208K for 13,514 services; 2024 $277K for 17,493 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 855 | 596 | $2.18 | $1,868 |
| 36415 Venipuncture Blood Collection | 229 | 183 | $8.65 | $1,981 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Osborn prescribed most often to Medicare patients was Tamsulosin Hcl, with 395 prescriptions and refills. In total David J Osborn wrote 1,761 Medicare prescriptions that cost $292K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 395 | 1,076 | 157 | $6,830 |
| Finasteride Generic | 233 | 686 | 77 | $4,233 |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 129 | 363 | 50 | $23K |
| Myrbetriq Mirabegron | 103 | 229 | 36 | $101K |
| Dutasteride Generic | 81 | 227 | 38 | $4,623 |
| Gemtesa Vibegron | 75 | 167 | 31 | $83K |
| Levofloxacin Generic | 52 | 52 | 38 | $389 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 150 | 25 | $1,411 |
| Potassium Citrate Er Potassium Citrate | 46 | 137 | 16 | $4,307 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 46 | 138 | 21 | $1,136 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 40 | 40 | 35 | $144 |
| Oxybutynin Chloride Generic | 40 | 75 | 15 | $599 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 36 | 91 | 13 | $3,606 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 35 | 35 | 30 | $924 |
| Estradiol Generic | 29 | 72 | 13 | $4,050 |
Brand drugs: - claims; generic drugs: 1,524 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Osborn $1,142 ($1,142 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $155 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $132 |
| Ferring Pharmaceuticals Inc. | 5 | $127 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $81.69 |
| Endo USA, Inc. | 3 | $79.17 |
| Janssen Biotech, Inc. JNJ | 4 | $70.74 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $57.99 |
| Pfizer Inc. PFE | 2 | $51.19 |
| Astellas Pharma US Inc 4503.T | 2 | $49.64 |
| Urogen Pharma, Inc. URGN | 2 | $41.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.